Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD206 inhibitors(Macrophage mannose receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Belgium | 30 Mar 2023 | |
| Atherosclerosis | Phase 2 | Belgium | 26 Jan 2021 | |
| Cardiac sarcoidosis | Phase 2 | Belgium | 26 Jan 2021 | |
| Carotid Stenosis | Phase 2 | Belgium | 26 Jan 2021 | |
| Head and Neck Neoplasms | Phase 2 | Belgium | 26 Jan 2021 | |
| Hodgkin's Lymphoma | Phase 2 | Belgium | 26 Jan 2021 | |
| Lymphohistiocytosis, Hemophagocytic | Phase 2 | Belgium | 26 Jan 2021 | |
| Non-Hodgkin Lymphoma | Phase 2 | Belgium | 26 Jan 2021 | |
| Hormone receptor negative HER2 positive breast cancer | Phase 2 | Belgium | 05 Nov 2019 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 2 | Belgium | 05 Nov 2019 |






